| Wnt signaling pathway in non-small cell lung cancer | Journal of the National Cancer Institute | 2014 | 405 |
| Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages | Proceedings of the National Academy of Sciences of the United States of America | 2014 | 111 |
| Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer | American Journal of Medicine | 2014 | 105 |
| Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial | Lancet Oncology, The | 2014 | 103 |
| Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results | Journal of the National Cancer Institute | 2014 | 92 |
| Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus | Practical Radiation Oncology | 2014 | 68 |
| Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects | Oncologist | 2014 | 57 |
| Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development | Journal of Pain and Symptom Management | 2014 | 55 |
| The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift | Journal of Obstetrics and Gynaecology Canada | 2014 | 53 |
| A Randomized, Open-Label, Phase III Trial of Afatinib (A) Vs Erlotinib (E) As Second-Line Treatment of Patients (Pts) with Advanced Squamous Cell Carcinoma (Scc) of the Lung Following First-Line Platinum-Based Chemotherapy: Lux-Lung 8 (Ll8) | Annals of Oncology | 2014 | 52 |
| Third-line chemotherapy in small-cell lung cancer: an international analysis | Clinical Lung Cancer | 2014 | 43 |
| Opportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in paroxysmal nocturnal hemoglobinuria | Medical Decision Making | 2014 | 42 |
| Wnt signaling pathway pharmacogenetics in non-small cell lung cancer | Pharmacogenomics Journal | 2014 | 36 |
| Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases | Journal of Surgical Oncology | 2014 | 35 |
| Piloting a regional collaborative in cancer surgery using a "community of practice" model | Current Oncology | 2014 | 31 |
| Cost effectiveness of a survivorship care plan for breast cancer survivors | Journal of Oncology Practice | 2014 | 31 |
| Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status | International Journal of Radiation Oncology Biology Physics | 2014 | 30 |
| Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters | British Journal of Radiology | 2014 | 27 |
| Patient perceptions and expectations regarding imaging for metastatic disease in early stage breast cancer | SpringerPlus | 2014 | 24 |
| Definition and consequences of locally advanced breast cancer | Current Opinion in Supportive and Palliative Care | 2014 | 21 |
| Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality | PLoS ONE | 2014 | 20 |
| Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer | Journal of Thoracic Oncology | 2014 | 18 |
| A prospective study of gastrointestinal radiation therapy-induced nausea and vomiting | Supportive Care in Cancer | 2014 | 18 |
| Synthesis and evaluation of the novel 2-[¹⁸F]fluoro-3-propoxy-triazole-pyridine-substituted losartan for imaging AT₁ receptors | Bioorganic and Medicinal Chemistry | 2014 | 15 |
| Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I study | Clinical Colorectal Cancer | 2014 | 15 |
